Cesson-Sevigne, France

Michel Levasseur

This inventor holds 1 USPTO granted patent. Top assignee: Landos Applications Orthopediques Francaises. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Levasseur - Innovator in Orthopedic Solutions

Introduction

Michel Levasseur is a notable inventor based in Cesson-Sevigne, France. He has made significant contributions to the field of orthopedics, particularly with his innovative designs aimed at improving medical treatments for bone fractures.

Latest Patents

One of Michel Levasseur's key inventions is the centro-medullary nailing rod. This device is designed for treating bone fractures and is characterized by its unique structure, which resembles a longitudinally split tube. The rod includes locking tongues that prevent or limit relative displacement between the edges of the slot while allowing transverse movement. This innovation enhances the rod's resistance to twisting, making it a valuable tool in orthopedic surgery. Michel holds 1 patent for this invention.

Career Highlights

Michel Levasseur is associated with Landos Applications Orthopediques Francaises, where he applies his expertise in developing orthopedic solutions. His work has been instrumental in advancing medical technology in this field.

Collaborations

Throughout his career, Michel has collaborated with talented individuals such as Frantz Langlais and Francis Chagneau. These partnerships have contributed to the success of his projects and innovations.

Conclusion

Michel Levasseur's contributions to orthopedic technology, particularly through his centro-medullary nailing rod, highlight his role as an innovator in the medical field. His work continues to impact the treatment of bone fractures positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…